33P Tumor-specific CD4 Th1 responses in long-term responder melanoma patients treated with immune checkpoint inhibitors

{"title":"33P Tumor-specific CD4 Th1 responses in long-term responder melanoma patients treated with immune checkpoint inhibitors","authors":"J. Mathiot , B. Ndao , L. Boullerot , A. Marguier , C. Laheurte , O. Adotevi , F. Aubin , C. Nardin","doi":"10.1016/j.iotech.2024.100915","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100915"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590018824002120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}